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Abstract
Background: Heart transplantation is an alternative for individuals with end-stage heart disease. However, episodes of 
heart rejection (HR) are frequent and increase morbidity and mortality, requiring the use of an accurate non-invasive 
exam for their diagnosis, since endomyocardial biopsy (EMB) is not a complication-free procedure.
Objective: To compare the parameters obtained by use of Doppler echocardiography in a group of transplanted patients 
with HR (TX1) and another group of transplanted patients without rejection (TX0), having as reference a control group 
(CG) and observing the behavior of the left ventricular systo-diastolic function expressed as the myocardial performance 
index (MPI)
Methods: Transthoracic echocardiographies were performed from January 2006 to January 2008 to prospectively assess 
47 patients divided into three groups: CG (36.2%); TX0 (38.3%); and TX1 (25.5%). The MPI was compared between the 
groups, and data were analyzed by use of Fisher exact test and nonparametric Kruskal-Wallis test, both with significance 
level of 5%. 
Results: The groups did not differ regarding age, weight, height, and body surface. When compared to GC, TX0 and TX1 
showed a change in the left ventricular systo-diastolic function, expressed as an increase in MPI, which was greater in 
TX1 [0.38 (0.29 – 0.44); 0.47 (0.43 – 0.56); 0.58 (0.52 – 0.74), respectively; p < 0.001].
Conclusion: Echocardiography was a very accurate test to detect changes in the systo-diastolic function of the 
transplanted heart; however, it did not prove to be reliable to replace BEM in the safe diagnosis of HR. (Arq Bras Cardiol 
2012;99(5):1031-1039)
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The beginning of the 1980s represents the beginning of the 
second phase of HT. It is known as the post-cyclosporine era or 
the era of HR control, in which an increase in the following was 
observed: the number of HT
4
; and one-year and five-year survival 
rates to approximately 80% and 65%, respectively, according to 
the most recent registry of the International Society for Heart and 
Lung Transplantation (ISHLT). However, although HR is no longer 
a restriction for transplantation, it still accounts for 12% of the 
adult deaths in the period between 30 and 360 days after HT
5
.
In Brazil, according to the Brazilian Society of Cardiology 
(SBC, in Portuguese) first guideline for HT registry, the one-year 
and four-year survival rates are 66% and 54%, respectively. Heart 
rejection has accounted for 18% of the deaths in that case series 
of 778 patients6.
Several non-invasive techniques for the diagnosis of rejection 
have been investigated, but, in clinical practice, none has proved 
to be sufficiently reliable to replace endomyocardial biopsy 
(EMB). However, routine biopsy is extremely inconvenient to 
patients, has risks, and increases costs. The strategy of performing 
biopsy one year after transplantation has been questioned, and 
attempts to reduce its frequency have been reported. However, 
Introduction
Heart failure (HF) is a clinical condition of high morbidity 
and mortality that affects approximately 23 million people 
worldwide
1
. In Brazil, approximately 6.4 million individuals 
are estimated to have HF. According to the Brazilian Ministry 
of Health, from January to July 2008, there were 147,348 
hospitalizations due to HF, with mortality rate of 8.1% (11,978 
patients) and estimated expenditure of R$ 132 million; in the 
Brazilian state of São Paulo, that cost exceeded R$ 25 million
2
.
The major complication of heart transplantation (HT) in its 
first decade was acute cellular rejection (heart rejection - HR) 
with elevated morbidity and mortality, and a survival rate lower 
than 15% per year. The difficulties for the early recognition 
of HR and of insufficient immunosuppression protocols were 
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Echocardiography is fundamental to manage transplanted 
patients. In the immediate postoperative period it enables the 
assessment of global systolic and diastolic functions, segmentary 
contractility, and hemodynamic parameters of both ventricles. 
In addition, echocardiography provides extremely accurate 
information about the severity of pulmonary hypertension and 
the diagnosis of valvular or pericardial changes, being ideal 
for follow-up and serial assessments
8
.  Echocardiography has 
advantages over EMB because it is less expensive, not restricted 
to large centers, rapidly performed, and has no complications. 
However, it cannot diagnose the type of rejection and requires 
properly trained professionals.
Objective
The objective of this study was to compare Doppler 
echocardiographic parameters in transplanted patients with 
HR (TX1) and without HR (TX0), using a control group (CG) 
as reference, and assessing the behavior of the left ventricular 
systo-diastolic function expressed by use of myocardial 
performance index (MPI).
Methods
From January 2006 to January 2008, patients who had 
undergone orthotopic HT according to the bicaval bipulmonary 
technique were assessed. They were recruited during 
hospitalization at the Real e Benemérita Associação Portuguesa 
de Beneficência de São Paulo, in the city of São Paulo, and 
were referred to EMB, which is the reference standard for the 
diagnosis of HR, at the Integrated Pathology Center of that 
hospital. All patients provided written informed consent, and 
the study was approved by the Ethics Committee in Research 
(nº 376-08) on 5/28/2008.
The patients used the triple regimen consisting of 
corticosteroids, a calcineurin inhibitor and antiproliferative 
drugs as follows: prednisolone (1 mg/kg/day)
9
; mycophenolate 
mofetil (500 mg, every 12 h); and cyclosporine (2 mg/kg/day). 
Some patients used azathioprine and methotrexate.
The inclusion criteria were as follows: patients with 
orthotopic HT due to cardiomyopathy of any etiology, at 
least seven days after surgery; age greater than 18 years; 
echocardiography performed at least seven days after EMB; and 
regular heart rhythm. Patients with the following characteristics 
were excluded: echocardiographic window technically 
inadequate to the satisfactory quality of the test; irregular heart 
rhythm; cardiac pacemaker (PM); EMB with insufficient material 
or inconclusive diagnosis; and fever at the time of the test.
The recipients had no information about the donors or 
their families.
Study design 
This was a prospective study, controlled with a group 
of healthy individuals. All transplanted patients underwent 
echocardiography and EMB, and the researchers involved in 
each of the two techniques knew nothing about the results 
of the other. The echocardiographic findings were correlated 
with the results of the EMB, considering the presence or 
absence of HR.
The CG consisted of healthy asymptomatic volunteers, 
with normal clinical exam, resting electrocardiography 
(ECG) and Doppler echocardiography, and history of neither 
cardiovascular nor systemic disease. The group of transplanted 
patients was subdivided into transplanted patients with HR 
(TX1) and without HR (TX0). The demographic data analyzed 
were as follows: sex (men, women); and color (white, mixed, 
and black). The groups had the same distribution of age, 
weight, height, and body surface (BS).
Clinical assessment
At the time EMB was indicated, the patients underwent 
anamnesis and clinical examination, and were classified 
according to New York Heart Association (NYHA) functional 
class to quantify the extension of HF, by use of the functional 
assessment regarding physical activity
10
. The etiology of the 
cardiomyopathy was investigated for HT indication.
Right ventricular endomyocardial biopsy
The EMBs were performed one day after echocardiography, 
via internal jugular vein puncture with radioscopic monitoring. 
Fragments of ventricular myocardium were obtained, sent to 
anatomical-pathological study by an experienced pathologist, 
and immediately reviewed by another pathologist, who ignored 
the report of the first pathologist. If the results disagreed, the 
samples would be sent to analysis of concordance by a third 
professional, which, however, was not necessary.
Cellular rejection was graded according to the ISHLT 
criteria as follows
11
: grade 0 = no rejection; grade IA = focal 
(perivascular or interstitial) infiltrate with no myocyte damage; 
grade IB = diffuse but sparse infiltrate with no myocyte damage; 
grade II = one focus only with aggressive infiltrates and/or 
myocyte damage; grade IIIA = multifocal aggressive infiltrates 
and/or myocyte damage; grade IIIB = diffuse inflammatory 
process with myocyte necrosis; and grade IV = diffuse 
aggressive polymorphous infiltrate with hemorrhage and 
myocyte necrosis. The biopsy specimens were considered 
adequate when at least three myocardial fragments were 
obtained for optical microscopy analysis, after formalin fixation 
and slide staining with hematoxylin and eosin. After sheath 
withdrawal, hemostasis was obtained with local compression.
Echocardiographic assessment
Echocardiography was performed with the Toshiba 
Nemio 30 Ultrasound System (Otawara-Shi, Tochigi, Japan), 
equipped with a 2.5- to 5.0-MHz multifrequency transducer. 
The patients were positioned in a left lateral decubitus for 
image acquisition in the parasternal and apical views. During 
the exam, heart rhythm and frequency were monitored by 
use of an electrocardiographic lead. All heart structures were 
measured according to the recommendations of the American 
Society of Echocardiography (ASE)
12-14
.
The exams were performed by an observer and immediately 
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to exclude intra- and interobserver variability. If the results 
disagreed, the exam would be performed by a third observer 
for concordance analysis. The echocardiographers were 
the same during the entire study, were highly experienced, 
with SBC level III training
15
. Three measurements for each 
echocardiographic variable were obtained, and their 
arithmetic mean was used for analysis.
The variables assessed were as follows: left ventricular 
diastolic diameter (LVDD); left ventricular diastolic volume 
(LVDV); interventricular septum thickness (IVST); left 
ventricular posterior wall thickness (LVPWT); relative wall 
thickness (RWT); ventricular mass indexed to body surface 
(VM/bs); left ventricular ejection fraction (LVEF); E wave 
deceleration time (EWDT); isovolumetric relaxation time 
(IVRT); ratio between the early and late ventricular filling 
velocities (E/A); peak early diastolic velocity on tissue Doppler 
echocardiography (E’); ratio between the early diastolic 
velocity of mitral flow and early diastolic velocity on tissue 
Doppler echocardiography (mitE/E’); left ventricular systole 
(LVS); left ventricular ejection time (LVET); and MPI.
Myocardial performance index
A new index for assessing the ventricular systo-diastolic 
function has been recently proposed, the MPI. Obtained 
by using Doppler echocardiography, and combining systolic 
and diastolic intervals of the cardiac cycle, the MPI value 
is lower than 0.39 ± 0.05 in normal individuals
16
, and 
increases as left ventricular function worsens (Figure 1). That 




The MPI does not require the analysis of ventricular borders, 
which is indispensable for calculating EF. Its measurement 
depends only on transmitral and transaortic flows, consisting 
in adding the left ventricular isovolumetric relaxation and 
contraction times, divided by LVET. It is adequate for diagnosing 
global cardiac dysfunction, because the greater its numerical 
value, the greater the grade of left ventricular dysfunction and 
worse the patient’s clinical status, being considered an indicator 
of high risk for congestive HF and death due to cardiac cause
18
.
The MPI seems to be independent of the geometry of the 
chamber, of changes in heart rate or blood pressure
19,20
, and of 
the severity of mitral regurgitation, although it depends partially 
on variations in filling
20
. The MPI is a reproducible method 
that closely correlates with invasive measures of systolic and 
diastolic functions.
To determine mitral transvalvular flow, the volume sample 
was positioned at the level of the extremities of the mitral cusps, 
and a biphasic pattern (above baseline) was obtained. The 
beginning of the flow reflects mitral valve opening, the first wave 
corresponding to the rapid ventricular filling phase, and the 
second wave corresponding to atrial contraction. To determine 
aortic transvalvular flow, the volume sample was positioned 
immediately below the valvular plane, and a monophasic 
pattern (below baseline), corresponding to ventricular ejection, 
was obtained21,22.
• left ventricular systole (a) - interval between the end of the 
second diastolic wave and the beginning of the first diastolic 
wave in mitral transvalvular flow.
• left ventricular ejection time (b) - interval between the 
beginning and end of the wave in aortic transvalvular flow.
Statistical analysis
  Data analysis was performed by using the SPSS (Statistical 
Package for Social Sciences) software for Windows, version 12, 
and R: A language and environment for statistical computing
23
. 
Figure 1 – Schematic representation for calculating the myocardial performance index, showing the mitral flow (top) and aortic flow (bottom) of the cardiac cycle, a: 
systolic interval; b: ejection time; ECG: electrocardiogram; ICT: isovolumetric contraction time; LVET: left ventricular ejection time; IVRT: isovolumetric relaxation time; 
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All tests were performed considering bilateral hypotheses and 
adopting the significance level of α = 5%.
Initially, descriptive statistics was used to assess the frequency, 
median and interquartile interval of the variables studied. 
Quantitative data were shown as median and interquartile 
interval. Qualitative data were shown as frequencies. 
Fisher exact test was used to assess the homogeneity of the 
proportions of men and women and of white and black/mixed 
individuals in the groups CG, TX0 and TX1. The nonparametric 
test was used, because the requirements for the parametric test 
were not met. 
The medians of the variables age, height, weight, and BS in 
the three groups were compared by use of the Kruskal-Wallis test, 
and, in the presence of a statistically significant difference, that test 
was followed by the multiple comparison test to identify which 
groups differed. A nonparametric test was also used, because 
those variables had no normal distribution, and the normality of 
the data was tested by use of the Kolmogorov-Smirnov test
24,25
.
In our sample, the proportion between women and men 
in groups CG, TX0 and TX1 differed. Thus, the groups were 
not homogeneous regarding sex. The same did not apply to 
the variable ethnicity, according to which the groups were 
homogeneous (Table 1).
In addition, the groups did not statistically differ regarding age, 
weight, height, and BS, being thus similar (Table 2).
At the time of EMB, of the TX0 patients, 15 were NYHA 
functional class II and three were NYHA functional class III; of 
the TX1 patients, two were NYHA functional class I, nine were 
NYHA functional class II, and one was NYHA functional class III 
(Chart 1). Of the 30 transplanted patients studied, HR was as 
follows: no HR, 18 patients (60%); grade IA HR, four patients 
(13.3%); grade IB HR, six patients (20%); and grade II HR, two 
patients (6.6%).
The most frequent etiologies of heart disease with HT 
indication were as follows: idiopathic dilated cardiomyopathy 
(31%); Chagas cardiomyopathy (29%); ischemic cardiomyopathy 
(25%); valvular heart disease (7%); restrictive cardiomyopathy 
(4%); and undetermined cause (4%).
Results
This study’s sample comprised 47 patients as follows: 17 
(36.2%) healthy individuals (CG); and 30 transplanted individuals, 
18 (38.3%) in the TX0 group and 12 (25.50%) in the TX1 group.
Of the transplanted patients, six were excluded from the study 
and not considered in the statistical analysis as follows: one due 
to technically inadequate echocardiographic window; two due 
irregular heart rhythm; one due to the presence of PM; and two 
due to insufficient EMB material. 
Some echocardiographic variables were also compared 
(Table 3).
Aiming at assessing the left ventricular systo-diastolic 
function by use of MPI, the LVS and the LVET of the cardiac 
cycle were assessed (Table 4).
A statistically significant difference was observed in the 
medians of the variables IVST, LVPWT, VM/bs, RWT and LVEF 
in the three groups as follows: the medians of the variables 
IVST, LVPWT, and VM/bs were lower in the CG than those in 
the TX0; the median of the variable LVEF was greater in the 
CG than that in the TX0. 
Regarding the variable RWT, its median in the CG was 
lower than those in the TX1 and TX0.
A statistically significant difference was also observed in the 
medians of the variables E’, EWDT and E/A in the three groups 
as follows: the median of the variable E’ was greater in the 
CG than that in the TX0; the median of the variable E/A was 
lower in the CG than those in the TX1 and TX0.
Regarding specifically the calculation of MPI, there was a 
statistically significant difference in the medians of the variables 
LVS, LVET and MPI between the three groups as follows: the 
median of the variable LVS was greater in CG than that in TX0; 
the median of the variable LVET was greater in CG than those 
in TX0 and TX1; the median of the variable MPI was lower 
in CG than those in TX0 and TX1. However, no difference in 
the medians of the two groups of transplanted patients was 
observed (Chart 2).
Assessing only the groups of transplanted patients, 40% 
had rejection and 60%, no rejection. Regarding the TX1, HR 
according to the ISHLT criteria was as follows: grade IB, 50%; 
grade IA, 33.33%; and grade II, 16.66%. No other HR grade 
was observed on EMB.
Discussion
Since the first HT was performed in South Africa in 1967, 
advances have provided longer survival to transplanted 
patients. The major improvement was the introduction, in 
the 1980s, of the immunosuppressive agent cyclosporine, 
which has boosted the interest in restarting the large-scale 
HT program, today limited due especially to the scarcity of 
donors available26. 
In the era of cyclosporine, rejection began to cause less 
myocardial edema, and, thus, measuring left ventricular mass 
has become obsolete as an isolated criterion to assess HR
27
. 
Our study has shown greater medians of IVST, LVPWT and 
VM/bs for transplanted patients as compared with those in the 
CG below the limits established for ventricular hypertrophy; 
however, no statistical significance was observed for the 
median of LVDD and for the calculation of LVDV, allowing us 
to infer that the increase in ventricular mass in transplanted 
patients occurs due to ventricular wall thickening.
Left ventricular diastolic dysfunction can be assessed by 
use of E/A, EWDT, IVRT and E’.
In our case series, no statistically significant difference 
was observed between the medians of the CG, TX0 and TX1 
regarding the analysis of IVRT; however, some statistically 
significant change in diastolic function could be identified, 
by comparing the medians and the interquartile intervals of 
the variables E’, EWDT and E/A between the three groups 
of patients.
Changes in diastolic function after HT are well known. 
The findings of this study are in accordance with those of 
the literature
26
, which have evidenced a pattern of restrictive 
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(32.5 – 54.5) 0.354




(57.5 – 73.5) 0.661




(1.64 – 1.72) 0.821




(1.63 – 1.88) 0.758
* Kruskal-Wallis test; CG: control group; TX0: transplanted patients without rejection; TX1: transplanted patients with rejection; IQI: interquartile interval (1st 
quartile – 3rd quartile); BS: body surface.
Chart 1 – Distribution of the 30 transplanted patients according to NYHA functional class (I, II and III) and presence of heart rejection. TX0: transplanted patients without 
rejection; TX1: transplanted patients with rejection.
 
 
Table 1 – Frequency and percentage of patients in the groups according to sex and ethnicity
GC TX0 TX1
p-value*
N  (%) N  (%) N  (%)
Sex
Female 8 (47.1) 1 (5.6) 2 (16.7)
0.012
Male 9 (52.9) 17 (94.4) 10 (83.3)
Ethnicity
White 15 (88.2) 16 (88.9) 12 (100.0)
0.660
Black/Mixed 2 (11.8) 2 (11.1) 0 (0.0)
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Assessing diastolic function is more sensitive in detecting 
rejection, because, according to the literature, diastolic changes 
precede any evidence of systolic dysfunction
9
. This is in 
accordance with data from this case series, whose medians of 
global left ventricular systolic function were increased (LVEF > 
50%) in all groups assessed.
Episodes of rejection are frequent after HT, and, when 
repeated, can cause fibrosis and ventricular cavity changes. By use 
of dobutamine, Bellotti et al.28 have reported normal contractility 
in transplanted patients with no rejection; however, in the 
presence of rejection, contractility was reduced
29
, suggesting 
that dobutamine echocardiography could aid in correlating with 
episodes of rejection.
The accuracy of MPI and its comparison with the method 
considered gold standard for quantifying EF have been studied by 
Lax et al.
30
, who have developed the formula, EF = 60 - (34 x MPI), 
transforming MPI into a widely known variable among clinicians. 
In recent years, a lot of effort has been put into discovering a 
non-invasive technique to replace EMB in patients undergoing 
HT. Because systolic and diastolic dysfunctions are present during 
episodes of HR, the Tei index has been investigated as a potential 
predictor of acute rejection
31
.
In our case series, MPI was greater in TX0 and in TX1 than 
in CG, both with statistical significance. In addition, MPI was 
greater in TX1 than in TX0, suggesting a possible worsening of 
systo-diastolic function in cases of HR; that hypothesis, however, 
could not be confirmed, because there was no statistical 
significance. Bellotti et al.28 have reported that, in the presence 
of an episode of rejection, the patients can have a reduction in 
the contractility reserve.








































(7.5 – 11.7) 0.006
CG ≠ Tx0
 CG = Tx1
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(0.36 – 0.46) <0.001
CG ≠ Tx0


































































(4.0 – 6.7) 0.283 –
* Kruskal-Wallis test; IQI: interquartile interval (1st quartile – 3rd quartile); CG: control group; TX0: transplanted patients without rejection; TX1: transplanted patients 
with rejection; LVDD: left ventricular diastolic diameter; LVDV: left ventricular diastolic volume; IVST: interventricular septum thickness; LVPWT: left ventricular posterior 
wall thickness; RWT: relative wall thickness; VM/bs: ventricular mass indexed to body surface; LVEF: left ventricular ejection fraction; EWDT: E wave deceleration 
time; IVRT: isovolumetric relaxation time; E/A: ratio between the peak early to the peak atrial mitral inflow velocities; E’: peak early diastolic velocity on tissue Doppler; 
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Chart 2 – Top: Box plot of the variables used to calculate the myocardial performance index. Left: box plot of the left ventricular systole (LVS) (p = 0.008), and right: box 
plot of the left ventricular ejection time (LVET) (p < 0.001) of control patients, and transplanted patients without rejection (TX0) and transplanted patients with rejection (TX1). 




















































MPI calculation; * Kruskal-Wallis test; IQI: interquartile interval (1st quartile – 3rd quartile); CG: control group; TX0: transplanted patients without rejection; TX1: 
transplanted patients with rejection; LVS: left ventricular systole; LVET: left ventricular ejection time; MPI: myocardial performance index
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A possible explanation for the increased values of MPI lies 
in the fact that the LVET is shorter in transplanted patients, 
and much shorter in the presence of HR, because of the 
pathophysiology of the graft, with no significant change in the 




The good correlation between echocardiographic changes 
and EMB results have suggested that Doppler echocardiography 
should be used as a first choice technique to aid in the non-




It has been shown that MPI is increased in transplanted 
patients as compared with a control group, and no 
significant difference was observed between the two groups 
of transplanted patients. Echocardiography showed good 
accuracy to detect changes in the systo-diastolic function of 
the transplanted heart; however, it did not prove to be reliable 
to replace BEM in the safe diagnosis of HR.
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